These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 54566)

  • 21. Continuous-flow plasmapheresis in management of severe rhesus disease.
    Graham-Pole J; Barr W; Willoughby ML
    Br Med J; 1977 May; 1(6070):1185-8. PubMed ID: 405071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complementary therapy for severe Rh-alloimmunization.
    Noia G; De Santis M; Romano D; Cavaliere AF; Ligato MS; Petrone A; Fortunato G; Filippetti F; Caruso A; Mancuso S
    Clin Exp Obstet Gynecol; 2002; 29(4):297-301. PubMed ID: 12635750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fetal transfusion.
    Queenan JT
    Fetal Ther; 1986; 1(1):59-64. PubMed ID: 3145669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhesus disease: the model for fetal therapy.
    Nicolaides KH; Rodeck CH
    Br J Hosp Med; 1985 Sep; 34(3):141-8. PubMed ID: 3933599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetal intracardiac transfusions in patients with severe rhesus isoimmunisation.
    Westgren M; Selbing A; Stangenberg M
    Br Med J (Clin Res Ed); 1988 Mar; 296(6626):885-6. PubMed ID: 3129060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of immunoglobulins in neonatal Rhesus haemolytic disease.
    Greenough A
    BioDrugs; 2001; 15(8):533-41. PubMed ID: 11543694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proper place of intrauterine transfusions in management of fetuses with Rh hemolytic disease.
    Boggs TR
    Clin Pediatr (Phila); 1970 Nov; 9(11):636-7. PubMed ID: 4991052
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful treatment of extremely severe fetal anemia due to Kell alloimmunization.
    Collinet P; Subtil D; Puech F; Vaast P
    Obstet Gynecol; 2002 Nov; 100(5 Pt 2):1102-5. PubMed ID: 12423822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal and intracardiac transfusion of recurrent fetal erythroblastosis due to anti-M alloimmunization with unfavorable outcome.
    Lin TH; Shih JC; Lin CH; Lin SY; Su YN; Lee CN
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):253-5. PubMed ID: 22795103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The outcome of babies of mothers with severe rhesus incompatibility treated at Tygerberg Hospital, 1980-1993.
    Kirsten GF; Steyn DW; Muller L; Geerts L; Riphagen S; de Beer R; Kriel J; Smith J; Odendaal HJ
    S Afr Med J; 1995 Oct; 85(10 Suppl):1091-6. PubMed ID: 8914559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization.
    Ruma MS; Moise KJ; Kim E; Murtha AP; Prutsman WJ; Hassan SS; Lubarsky SL
    Am J Obstet Gynecol; 2007 Feb; 196(2):138.e1-6. PubMed ID: 17306655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of fetal hemolytic disease using plasmapheresis].
    Schwarzlos G; During R; Müller S; Stark KH; Plesse R
    Zentralbl Gynakol; 1989; 111(24):1599-603. PubMed ID: 2624011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Planned conception in a hyper immunized rhesus-d negative mother by elective plasmapheresis.
    Ayesha K; Habibullah MM; Biswas J; Begum HA; Sultana R
    Mymensingh Med J; 2007 Jul; 16(2 Suppl):S67-69. PubMed ID: 17917636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
    J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and treatment of erythroblastosis in the fetus.
    Liley AW
    Adv Pediatr; 1968; 15():29-63. PubMed ID: 4966222
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of rhesus haemolytic disease upon birthweight.
    Binks AS; Lind T; McNay RA
    J Obstet Gynaecol Br Commonw; 1973 Apr; 80(4):301-4. PubMed ID: 4634176
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent advances in the management of Rh hemolytic disease of the newborn (HDN).
    Gupte SC
    Indian J Med Sci; 1995 Mar; 49(3):66-72. PubMed ID: 7558217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.